A citation-based method for searching scientific literature

F Miglietta, M Bottosso, G Griguolo, M V Dieci, V Guarneri. ESMO Open 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment landscape of triple-negative breast cancer - expanded options, evolving needs.
Giampaolo Bianchini, Carmine De Angelis, Luca Licata, Luca Gianni. Nat Rev Clin Oncol 2022
36
100

Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis.
Sashidhar Manthravadi, Anuj Shrestha, Sheshadri Madhusudhana. Int J Cancer 2016
84
100

Breast cancer.
Sibylle Loibl, Philip Poortmans, Monica Morrow, Carsten Denkert, Giuseppe Curigliano. Lancet 2021
133
100

Targeting p53 for the treatment of cancer.
Michael J Duffy, Naoise C Synnott, Shane O'Grady, John Crown. Semin Cancer Biol 2022
56
100

Pleiotropic effects of statins: A focus on cancer.
Mazaher Ahmadi, Shayan Amiri, Stevan Pecic, Filip Machaj, Jakub Rosik, Marek J Łos, Javad Alizadeh, Reza Mahdian, Simone C da Silva Rosa, Dedmer Schaafsma,[...]. Biochim Biophys Acta Mol Basis Dis 2020
36
100

Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?
N C Synnott, A Murray, P M McGowan, M Kiely, P A Kiely, N O'Donovan, D P O'Connor, W M Gallagher, J Crown, M J Duffy. Int J Cancer 2017
53
100

Therapeutic effects of statins against lung adenocarcinoma via p53 mutant-mediated apoptosis.
Cheng-Wei Chou, Ching-Heng Lin, Tzu-Hung Hsiao, Chia-Chien Lo, Chih-Ying Hsieh, Cheng-Chung Huang, Yuh-Pyng Sher. Sci Rep 2019
29
100

The interplay between cell signalling and the mevalonate pathway in cancer.
Peter J Mullen, Rosemary Yu, Joseph Longo, Michael C Archer, Linda Z Penn. Nat Rev Cancer 2016
277
100

A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).
S Ramalingam, G Goss, R Rosell, G Schmid-Bindert, B Zaric, Z Andric, I Bondarenko, D Komov, T Ceric, F Khuri,[...]. Ann Oncol 2015
72
100

The therapeutic target Hsp90 and cancer hallmarks.
Yoshihiko Miyata, Hitoshi Nakamoto, Len Neckers. Curr Pharm Des 2013
190
100

Association of statin use with clinical outcomes in patients with triple-negative breast cancer.
Malgorzata K Nowakowska, Xiudong Lei, Mikayla T Thompson, Simona F Shaitelman, Mackenzie R Wehner, Wendy A Woodward, Sharon H Giordano, Kevin T Nead. Cancer 2021
7
100

Simvastatin Induces Apoptosis and Suppresses Insulin-Like Growth Factor 1 Receptor in Bile Duct Cancer Cells.
Jin Lee, Eun Mi Hong, Ju Ah Jang, Se Woo Park, Dong Hee Koh, Min Ho Choi, Hyun Joo Jang, Sea Hyub Kae. Gut Liver 2016
18
100

Targeting HSP90 for cancer therapy.
D Mahalingam, R Swords, J S Carew, S T Nawrocki, K Bhalla, F J Giles. Br J Cancer 2009
202
100

Atorvastatin administration is associated with dose-related changes in IGF bioavailability.
Ram P Narayanan, Matthew Gittins, Kirk W Siddals, Robert L Oliver, Julie E Hudson, Anne White, Paul Durrington, Robert R Davies, Martin K Rutter, J Martin Gibson. Eur J Endocrinol 2013
7
100

Statin Toxicity.
Natalie C Ward, Gerald F Watts, Robert H Eckel. Circ Res 2019
201
100


Statin induces apoptosis of human colon cancer cells and downregulation of insulin-like growth factor 1 receptor via proapoptotic ERK activation.
Hyun Joo Jang, Eun Mi Hong, Se Woo Park, Hyun Woo Byun, Dong Hee Koh, Min Ho Choi, Sea Hyub Kae, Jin Lee. Oncol Lett 2016
23
100

Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins.
Federica Iannelli, Rita Lombardi, Maria R Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon, Francesca Bruzzese. Recent Pat Anticancer Drug Discov 2018
60
100

Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins.
Tomasz Sitar, Grzegorz M Popowicz, Igor Siwanowicz, Robert Huber, Tad A Holak. Proc Natl Acad Sci U S A 2006
112
100

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.
Signe Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, Judy E Garber, Marco Colleoni, István Láng, Marc Debled, Bent Ejlertsen, Roger von Moos, Ian Smith,[...]. J Clin Oncol 2017
70
100

Statins Reduce Intratumor Cholesterol Affecting Adrenocortical Cancer Growth.
Francesca Trotta, Paola Avena, Adele Chimento, Vittoria Rago, Arianna De Luca, Sara Sculco, Marta C Nocito, Rocco Malivindi, Francesco Fallo, Raffaele Pezzani,[...]. Mol Cancer Ther 2020
6
100

Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced N-glycosylation Abundance and Branching.
Rosemary Yu, Joseph Longo, Jenna E van Leeuwen, Cunjie Zhang, Emily Branchard, Mohamad Elbaz, David W Cescon, Richard R Drake, James W Dennis, Linda Z Penn. Cancer Res 2021
11
100

Drugging the 'undruggable' cancer targets.
Chi V Dang, E Premkumar Reddy, Kevan M Shokat, Laura Soucek. Nat Rev Cancer 2017
369
100

Recombinant PAPP-A resistant insulin-like growth factor binding protein 4 (dBP4) inhibits angiogenesis and metastasis in a murine model of breast cancer.
Y E Smith, S Toomey, S Napoletano, G Kirwan, C Schadow, A J Chubb, J H Mikkelsen, C Oxvig, J H Harmey. BMC Cancer 2018
9
100


IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells.
Damiano Cosimo Rigiracciolo, Nijiro Nohata, Rosamaria Lappano, Francesca Cirillo, Marianna Talia, Domenica Scordamaglia, J Silvio Gutkind, Marcello Maggiolini. Cells 2020
29
100

Expression of a protease-resistant insulin-like growth factor-binding protein-4 inhibits tumour growth in a murine model of breast cancer.
A J Ryan, S Napoletano, P A Fitzpatrick, C A Currid, N C O'Sullivan, J H Harmey. Br J Cancer 2009
50
100

Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implications for therapy.
Zoë Davison, Gail E de Blacquière, Bruce R Westley, Felicity E B May. Neoplasia 2011
97
100

Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
Sixten Harborg, Uffe Heide-Jørgensen, Thomas P Ahern, Marianne Ewertz, Deirdre Cronin-Fenton, Signe Borgquist. Breast Cancer Res Treat 2020
15
100

Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis.
Eleonora Ingallina, Giovanni Sorrentino, Rebecca Bertolio, Kamil Lisek, Alessandro Zannini, Luca Azzolin, Luisa Ulloa Severino, Denis Scaini, Miguel Mano, Fiamma Mantovani,[...]. Nat Cell Biol 2018
65
100

A phase 2 clinical trial of the heat shock protein 90 (HSP 90) inhibitor ganetespib in patients with refractory advanced esophagogastric cancer.
Lipika Goyal, Surendra Pal Chaudhary, Eunice L Kwak, Thomas A Abrams, Amanda N Carpenter, Brian M Wolpin, Raymond C Wadlow, Jill N Allen, Rebecca Heist, Nadine Jackson McCleary,[...]. Invest New Drugs 2020
7
100

The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies.
Lindsay Angus, Marcel Smid, Saskia M Wilting, Job van Riet, Arne Van Hoeck, Luan Nguyen, Serena Nik-Zainal, Tessa G Steenbruggen, Vivianne C G Tjan-Heijnen, Mariette Labots,[...]. Nat Genet 2019
126
100


Mutant p53 in cancer: new functions and therapeutic opportunities.
Patricia A J Muller, Karen H Vousden. Cancer Cell 2014
931
100


High-dose atorvastatin is associated with lower IGF-1 levels in patients with type 1 diabetes.
Karin Bergen, Kerstin Brismar, Sara Tehrani. Growth Horm IGF Res 2016
6
100

DNAJA1 controls the fate of misfolded mutant p53 through the mevalonate pathway.
Alejandro Parrales, Atul Ranjan, Swathi V Iyer, Subhash Padhye, Scott J Weir, Anuradha Roy, Tomoo Iwakuma. Nat Cell Biol 2016
126
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.